Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MEDIMMUNE INC /DE | 60,000 | reported | 23 Feb 2006 | tx 4+72,000−24,000 |
| PALVELLA THERAPEUTICS, INC. | 40,000 | reported | 21 Jun 2023 | tx 7+230,000 |
| Cue Biopharma, Inc. | 24,400 | reported | 02 Jan 2026 | tx 18+158,658−59,359 |
| LAVA Therapeutics NV | 0 | reported | 13 Nov 2025 | tx 2+33,390−33,390 |
| Sucampo Pharmaceuticals, Inc. | 0 | reported | 13 Feb 2018 | tx 21+448,622−681,055 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jan 2026 | GRANT_AWARD | Cue Biopharma, Inc. | 24,400 | 0.00 USD | deriv |
| 13 Nov 2025 | OTHER | LAVA Therapeutics NV | 33,390 | 0.00 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | LAVA Therapeutics NV | 33,390 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Cue Biopharma, Inc. | 24,400 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Cue Biopharma, Inc. | 24,400 | 0.00 USD | deriv |
| 21 Jun 2023 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 40,000 | 0.00 USD | deriv |
| 23 Mar 2023 | EXERCISE | Cue Biopharma, Inc. | 9,682 | 2.86 USD | |
| 23 Mar 2023 | SALE | Cue Biopharma, Inc. | 9,325 | 3.28 USD | |
| 23 Mar 2023 | EXERCISE | Cue Biopharma, Inc. | 9,682 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Cue Biopharma, Inc. | 10,000 | 0.00 USD | deriv |
| 22 Jun 2022 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 40,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Cue Biopharma, Inc. | 10,000 | 0.00 USD | deriv |
| 15 Nov 2021 | EXERCISE | Cue Biopharma, Inc. | 18,815 | 2.86 USD | |
| 15 Nov 2021 | SALE | Cue Biopharma, Inc. | 18,815 | 17.92 USD | |
| 16 Nov 2021 | SALE | Cue Biopharma, Inc. | 1,361 | 18.02 USD | |
| 16 Nov 2021 | EXERCISE | Cue Biopharma, Inc. | 1,361 | 2.86 USD | |
| 15 Nov 2021 | EXERCISE | Cue Biopharma, Inc. | 18,815 | 0.00 USD | deriv |
| 16 Nov 2021 | EXERCISE | Cue Biopharma, Inc. | 1,361 | 0.00 USD | deriv |
| 25 Jun 2021 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 40,000 | 0.00 USD | deriv |
| 04 Jan 2021 | GRANT_AWARD | Cue Biopharma, Inc. | 10,000 | 0.00 USD | deriv |
| 23 Jun 2020 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 40,000 | 0.00 USD | deriv |
| 25 Jan 2020 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 20,000 | 0.00 USD | deriv |
| 02 Jan 2020 | GRANT_AWARD | Cue Biopharma, Inc. | 8,000 | 0.00 USD | deriv |
| 25 Jan 2019 | GRANT_AWARD | PALVELLA THERAPEUTICS, INC. | 20,000 | 0.00 USD | deriv |
| 02 Jan 2019 | GRANT_AWARD | Cue Biopharma, Inc. | 8,000 | 0.00 USD | deriv |